7th Health Innovation Conference

"Health innovation: Value, barriers and exciting prospects"

Over recent years, exciting developments in genetics and major technological progress, culminating in the introduction of next generation sequencing (NGS) for DNA have opened up previously uncharted avenues for understanding the genetics not only of cancer but also of other diseases, allowing the development of new diagnosis and treatment methods.

Experts also term this as Precision Medicine or Personalized Medicine. Thanks to advanced diagnostic tools (biomarkers), doctors are searching for the genetic mutations responsible in tumors and then administering revolutionary targeted treatments aimed precisely at the said mutations.

All these innovative applications of precision medicine were discussed at the Health Innovation Conference 2023 which was held physical at the Divani Caravel Hotel and digital through LiveOn, the integrated platform for Digital Communication and Events, and its innovative 3D exposition and conference center LiveOn Expo Complex. The conference was organized by ethosEVENTS in partnership with the health information portal virus.com.gr and health policy magazine Pharma & Health Business.

Coordinator of the conference was Mr. Emilios Negis, journalist and editor of Pharma & Health Business and virus.com.gr.

Closed (Hybrid) Lobbying Workshop

During the conference, a Closed Lobbying Workshop was held on the value of medical innovation with the participation of all political parties in order to position themselves.

The evaluation of and compensation for innovative medicines, medical devices, biomarkers and mobile phone applications will be on the table.

The workshop was organized as a hybrid event, with physical presence of participants at Divani Caravel Hotel and top executives of the conference sponsors, while the option of digital attendance was available through LiveOn Expo Complex.

Coordinator of the closed meeting was Mr. Emilios Negis, journalist and editor of Pharma & Health Business and Virus.com.gr.

Overview

The 7th Health Innovation Conference included important speeches and panels with the following key matters.

Panel 1:”Greek pharmaceutical industry: Favorable prospects from investments in innovation”

The pandemic opened up new paths for the development of the pharmaceutical industry at European level. Europe came face to face with its own lack of autonomy, realizing quite how dependent it was on America in terms of Research and Development (R&D), and on China and India in terms of raw materials and pharmaceutical production.

The European Commission has now set itself the objective of changing that research and production model. One of the main pillars of the new European Pharmaceutical Strategy is to bolster and repatriate innovation and production to European territories.

With that in mind, there are favorable prospects for Greece. The Greek pharmaceutical industry already exports first-line medicines to more than 140 countries and at the same time is implementing a dynamic investment plan with € 1.2 billion being spent over a four-year period.

The plan provides for the construction of new factories and research centers. For example:

  • DEMO is setting up, among other things, a modern Biotechnology Research Center in Agios Stefanos, Attica, which will have Biotechnology Research & Development Laboratories and a model monoclonal antibody production unit for batch production for clinical trial purposes.
  • ELPEN is moving ahead with, among other things, the creation of a Research and Innovation Park in Spata, Attica, and a new plant with two oncology medicine production plants in Tripoli.

These investments have a unique multiplier effect on public revenues and the country’s GDP, and result in the creation of new, well-paid jobs.

At the same time, the government has set a goal for Greece to become a hub for biotechnological research. The biotechnology sector is considered one of the most robust and dynamic sectors worldwide.

It is estimated that by 2030 the value of the biotechnology market will reach $2.2 trillion compared to $600 billion dollars in 2020, and 70% of the global health insurance funds’ budget will concern biotech preparations.

Subjects

  • How Greek pharmaceutical industry investments are developing
  • R&D and innovation challenges
  • How the international environment is shaping up
  • Utilizing the Recovery Fund
  • Attracting foreign investments

Panel 2: “The role of biomarkers and the need to modernize the evaluation and compensation framework”

In recent years there have been rapid developments when it comes to the creation and use of new targeted therapies for almost all types of cancer. Biomarkers are key to finding and selecting those patients who need to receive these targeted therapies. Those patients are detected through special molecular tests.

Unfortunately, Greece lags considerably behind in this sector. Currently, only 33 biomarkers related to cancer are reimbursed by Greece’s national healthcare provider EOPYY, but the relevant list has not been updated since 2014.

Thus, many patients pay the usually high cost of these biomarker tests out of pocket or the cost is borne by the Hellenic Society of Medical Oncology (HESMO) and pharmaceutical companies.

It is illustrative that HESMO has implemented 21 Biomarker Detection Programs, offering free tests to more than 4500 oncology patients. The cost has exceeded €5.6 million and has been covered by its own resources and significant sponsorship from the pharmaceutical industry.

Experts stress that the list of biomarkers reimbursable by EOPYY needs to be updated immediately. To this end, a specific and documented proposal will be presented at the round table, concerning the framework for the evaluation and reimbursement of biomarkers. The proposal has been prepared by the Hellenic Institute of Health Economics.

Subjects

  • The role of biomarkers in the treatment of cancer patients
  • Accreditation of private and public laboratories
  • What are the prospects?
  • Challenges in evaluating and reimbursing biomarkers

Panel 3: “Theranostics: A new era in personalized cancer diagnosis and treatment”

The term “THERANOSTICS” is a combination of the words Therapeutics and Diagnostics. This is an emerging field developed by nuclear medicine and is a combination of imaging and radiation therapy at the molecular level.

Put simply, it is a method that allows doctors, using special radiopharmaceuticals, “to see what they want to treat and to treat what they see”.

The chemical composition of radiopharmaceuticals used for diagnostic imaging and treatment is exactly the same, with the exception of the isotopes used, which may be diagnostic isotopes for imaging and therapeutic isotopes for treatment.

New treatments have already been launched for the treatment of neuroendocrine tumors of the gastrointestinal pancreatic system and prostate cancer, while studies on the use of radiopharmaceuticals in the diagnosis and targeted treatment of oncology patients are under way.

Subjects

  • The role of radiopharmaceuticals in cancer diagnosis and treatment
  • What are the current applications and the results
  • What are the challenges and prospects for using radiopharmaceuticals?

Panel 4: “Precision medicine: Research – challenges – prospects”

In recent years, medicine has changed rapidly. A key feature of the changes is that new diagnostic tools and treatment methods are being developed, which have been designed based on the genetic material and the individual needs of each patient.

This is not science fiction. Gene therapies are already available for rare diseases and there are also expensive cell therapies, which also concern rare and incurable forms of cancer. And their number is increasing steadily and with greater speed.

It is indicative that while we had only 5 personalized treatments in 2008, today there are more than 300! These numbers are only just the beginning. Analysis showed that 61% of clinical trials for cancer treatments conducted in 2019 related to the use of biomarkers, compared to just 18% in 2000!

In 2022, the US Food and Drug Administration (FDA) approved 12 personalized treatments, accounting for 34% of new treatments. For example, 5 cell therapies were approved for rare diseases such as thalassaemia, haemophilia B, and cerebral adrenoleukodystrophy.

However, there are major challenges internationally. Barriers to the adoption of new therapies in clinical practice and skepticism about the expected benefits of precision medicine continue to make it difficult for health systems around the world to capitalize on groundbreaking scientific and technological advances.

Experts point out that the public, health professionals, and the authorities need to be informed about the value of Precision Medicine and personalized treatments.

Audience:

  • the political leadership of the Ministry of Health
  • executives from public and private hospitals
  • renowned doctors
  • patients’ associations representatives
  • executives involved in the medical technology products market
  • journalists

Agenda

03/05/23

Sponsors

Gold Sponsor

GENEKOR_LOGO_SITE

Silver Sponsors

ΒΙΟΚΟΣΜΟΣ_SITE
IQVIA

Bronze Sponsors

DEMO_SITE

Premium Corporate Participations

AFFIDEA_SITE

Corporate Participations

INNEWS

under the Auspices of

pif_new
sfee-40-gr-logo
PEF_SITE
isa_logo_site
ESPY
hdhc-1-new
sekee
elema_logo

Communication Sponsors

VIRUS_NEW
phb_logo
BANKS
exposgreece_logo
star_ken_el_logo
tvstar_new_1
piraeus365gr_logo
BEC_Logo
xrima
xrimaweek
insuranceworld
insuranceworldgr

Sponsorship Program

GOLD SPONSOR (€12,000 + VAT)

  • Sponsors will be prominently featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • The option is provided for the publication of an interview of a high-ranking executive in Pharma & Health Business magazine, to be reposted on the virus.com.gr portal.
  • One sponsor executive is entitled to a ten-minute (10) speech.
  • Sponsors are entitled to have an executive participate in a conference panel.
  • Sponsors are entitled to have three (3) executives physically present and three (3) executives participate digitally at the Closed (Hybrid) Lobbying Workshop.
  • The sponsor’s logo (and/or a design containing it) will be prominently featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs on the building’s exterior, in the Lobby/Zone Α, in the VIP Lounge, in the Conference Center Lobby, and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to a Premium 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 30 MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors will be able to leave their contact details, get information on the company profile (500 words maximum), download the company profile and request a meeting with a Sponsor’s representative), 3. Company Video (area where visitors will have access to a company presentation video – of 5′ maximum duration), 4. Product Promotion Placements (2x) (two placements of photographic material where visitors will be able to get information on the company’s products), 5. Meeting Point (where visitors will have the opportunity to meet with company’s representatives who are present at the stand (their profiles will be visible on pop-ups) and interact with them (through pop-ups) by instant chat, instant or scheduled video call, instant or scheduled B2B meeting) and 6. Product Catalogue Placements (2x).
  • At the Digital Stand, up to eight (8) executives of the Sponsor will be able to connect and communicate online. Visitors who request some form of communication with an executive, will automatically be notified of the latter’s contact information (e-business card).
  • They are entitled to space to set up a kiosk, maximum dimensions 3m x 3m, in the lobby of the hotel where the conference will be held.
  • They are entitled to fifty (50) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to three (3) eight-person round tables (24 people) in the conference area.
  • Sponsors may opt to screen an advertisement spot (20” maximum duration). This ad spot may be played up to three (3) times during the conference’s advertisement slots.
  • Sponsors will be promoted via the organizer’s social media (Facebook and LinkedIn) with three (3) “featured” posts.
  • They are entitled to include up to (30 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

SILVER SPONSOR (€9,000 + VAT)

  • Sponsors will be prominently featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • The option is provided for the publication of an interview of a high-ranking executive on the virus.com.gr portal.
  • One sponsor executive is entitled to a ten-minute (10) speech or to participate in a conference panel.
  • Sponsors are entitled to have two (2) executives physically present and two (2) executives participate digitally at the Closed (Hybrid) Lobbying Workshop.
  • The sponsor’s logo (and/or a design containing it) will be prominently featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs on the building’s exterior, in the Lobby/Zone Α, in the VIP Lounge, in the Conference Center Lobby, and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to a Premium 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 20 MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors will be able to leave their contact details, get information on the company profile (500 words maximum), download the company profile and request a meeting with a Sponsor’s representative), 3. Company Video (area where visitors will have access to a company presentation video – of 5′ maximum duration), 4. Product Promotion Placements (2x) (two placements of photographic material where visitors will be able to get information on the company’s products). 5. Meeting Point (where visitors will have the opportunity to meet with company’s representatives who are present at the stand (their profiles will be visible on pop-ups) and interact with them (through pop-ups) by instant chat, instant or scheduled video call, instant or scheduled B2B meeting) and 6. Product Catalogue Placements (2x).
  • At the Digital Stand, up to six (6) executives of the Sponsor will be able to connect and communicate online . Visitors who request some form of communication with an executive, will automatically be notified of the latter’s contact information (e-business card).
  • They are entitled to space to set up a kiosk, maximum dimensions 3m x 2m, in the lobby of the hotel where the conference will be held.
  • They are entitled to forty (40) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to two (2) eight-person round tables (16 people) in the conference area.
  • Sponsors may opt to screen an advertisement spot (20” maximum duration). This ad spot may be played up to two (2) times during the conference’s advertisement slots.
  • Sponsors will be promoted via the organizer’s social media (Facebook and LinkedIn) with two (2) “featured” posts.
  • They are entitled to include up to (20 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

BRONZE SPONSOR (€6,000 + VAT)

  • Sponsors will be prominently featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • Sponsors are entitled to have one (1) executive physically present and one (1) executive participate digitally at the Closed (Hybrid) Lobbying Workshop.
  • The sponsor’s logo (and/or a design containing it) will be prominently featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs in the Lobby/Zone Α, in the Conference Center Lobby — subject to availability — and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to an Advanced 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 10 MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors will be able to leave their contact details, get information on the company profile (500 words maximum), download the company profile and request a meeting with a Sponsor’s representative), 3. Company Video (area where visitors will have access to a company presentation video – of 5′ maximum duration), 4. Product Promotion Placement (1x) (one placement of photographic material where visitors could get information on the company’s products), 5. Meeting Point (where visitors will have the opportunity to meet with company’s representatives who are present at the stand (their profiles will be visible on pop-ups) and interact with them (through pop-ups) by instant chat, instant or scheduled video call, instant or scheduled B2B meeting) and 6. Product Catalogue Placement (1x).
  • At the Digital Stand, up to four (4) executives of the Sponsor will be able to connect and communicate online. Visitors who request some form of communication with an executive, will automatically be notified of the latter’s contact information (e-business card).
  • They are entitled to space to set up a kiosk, maximum dimensions 2m x 2m, in the lobby of the hotel where the conference will be held.
  • They are entitled to thirty (30) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to one (1) eight-person round table (8 people) in the conference area.
  • Sponsors may opt to screen an advertisement spot (20” maximum duration). This ad spot may be played once (1) during the conference’s advertisement slots.
  • Sponsors will be promoted via the organizer’s social media (Facebook and LinkedIn) with one (1) “featured” post.
  • They are entitled to include up to (10 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

PREMIUM CORPORATE PARTICIPATION (€3,000 + VAT)

  • Sponsors will be featured throughout the conference’s promotional material. (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • Sponsors are entitled to have one (1) executive participate physically or digitally in the Closed (Hybrid) Lobbying Workshop.
  • The sponsor’s logo (and/or a design containing it) will be featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs in the Lobby/Zone B — subject to availability —, in the Conference Center lobby — subject to availability —, and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to a Standard 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 8MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors could leave their contact details, get information on the company profile (150 words maximum), 3. Company Video (area where visitors will have access to a company presentation video – of 3′ maximum duration), 4. Product Promotion Placement (1x) (one placement of photographic material where visitors could get information on the company’s products).
  • They are entitled to display one (1) roll up banner, maximum dimensions 0.85m x 2.00m, in the lobby of the hotel where the conference will be held.
  • They are entitled to twenty (20) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to invite four (4) guests to attend the conference in person.
  • They are entitled to include up to (8 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

CORPORATE PARTICIPATION (€1,500 + VAT)

  • The sponsor’s logo will be featured on the conference’s graphics. (on the conference main website, the Sponsor section landing page, and the presentation – speech pages).
  • Sponsors are entitled to have one (1) executive participate digitally in the Closed (Hybrid) Lobbying Workshop.
  • They are entitled to ten (10) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to invite two (2) guests to attend the conference in person.
  • They are entitled to include up to (5 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

INDIVIDUAL PARTICIPATION

€290 + 24% VAT – hybrid participation (physically & digitally present via the LiveOn Expo Complex)

€90 + 24% VAT – digital participation (via the LiveOn Expo Complex)

Provisions per individual participations:

  • Participation in conference proceedings.
  • Full utilization of the advanced digital capabilities of the LiveOn Expo Complex (networking, XPack, video calls & chats).
  • Conference attendance certificate (to be sent by e-mail)
  • Online exchange of contact details and personal communication with speakers, conference participants, and participating sponsor executives through the event’s Networking Hub.
  • All participants will receive a detailed report of the conference (including speaker presentations, videos, and photos).
LiveOn Expo Complex Branding Spots
Share This Event
Event Details
Event Details
    Contact

    For information on sponsorship programs

    Konstantinos Ouzounis, CEO, ethosGROUP
    tel:+30 210 998 4864,
    e-mail: [email protected]
     
    Christos Charalambakis, Key Account Manager, 
    tel:+ 210 998 4915, 
    e-mail: [email protected]

    Program Manager

    Emilios Negis, Managing Editor, Pharma & Health Business, virus.com.gr,
    tel:+ 210 998 4950

    For information on the program & Auspices

    Mariana Vazaiou, Head of Events Content,
    tel:+30 210 998 4932,
     
    Stamatina Farkona , Events Programme Executive,
    tel:+30 210 998 4933,

    Marketing & Communication Sponsors

    Andreas Baltas, Group Digital Marketing Manager,
    tel:+30 210 998 4906,
     
    Georgia Koutsougera, Marketing Assistant,
    tel:+30 210 998 4934,

    Event Coordinator

    Konstantinos Salvarlis, Events Director,
    tel:+30 210 998 4909,
     
    Aris Lavdis, Associate Director, Events,
    tel:+30 210 998 4814,
     
    Panos Halavazis, Hybrid Events Supervisor
    tel:+30 210 998 4921 

    Individual Participations

    Stavroula Oikonomaki, Key Account Manager, 
    tel:+30 210 998 4876, 
    e-mail: [email protected]
    Past Events

    6th Health Innovation Conference
    Conference | Report

    5th Health Innovation Conference
    Conference | Report

    4th Health Innovation Conference
    Conference | Report